<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

ACAAI Presentation Highlights Roflumilast’s Efficacy and Safety

Default sub title

minute read

by Dermatology Times | October 24, 2024
placeholder

Topics: Press Coverage